CANERTINIB
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | INHIBITOR | Receptor protein-tyrosine kinase erbB-2 inhibitor | no | 3 | 0 |
education-academy-coach domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /local/apache-stuff/gbm_portal/wp-includes/functions.php on line 6121education-insight domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /local/apache-stuff/gbm_portal/wp-includes/functions.php on line 6121| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | INHIBITOR | Receptor protein-tyrosine kinase erbB-2 inhibitor | no | 3 | 0 |